Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma-Reference-Cited by-同舟云学术

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma

Published:2016-12-27 Issue:8 Volume:31 Page:1735-1742
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

da Silva Filho M I,Försti A,Weinhold N,Meziane I,Campo C,Huhn S,Nickel J,Hoffmann P,Nöthen M M,Jöckel K-H,Landi S,Mitchell J S,Johnson D^ORCID,Morgan G J,Houlston R,Goldschmidt H,Jauch A,Milani P,Merlini G,Rowcieno D,Hawkins P,Hegenbart U,Palladini G^ORCID,Wechalekar A,Schönland S O,Hemminki K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu2016387.pdf

Reference57 articles.

1. Hemminki K, Li X, Forsti A, Sundquist J, Sundquist K . Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health 2012; 12: 974.

2. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525–532.

3. Blancas-Mejia LM, Ramirez-Alvarado M . Systemic amyloidoses. Annu Rev Biochem 2013; 82: 745–774.

4. Merlini G, Seldin DC, Gertz MA . Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924–1933.

5. Ramirez-Alvarado M . Amyloid formation in light chain amyloidosis. Curr Top Med Chem 2012; 12: 2523–2533.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges;Journal of the Peripheral Nervous System;2024-06

2. Amyloid Light Chain (AL) Amyloidosis;Cardiac Amyloidosis;2024

3. Hematological Associations in Amyloidosis;Amyloidosis and Fabry Disease;2023

4. Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6;Blood Cancer Journal;2022-04-13

5. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis;Critical Reviews in Oncology/Hematology;2021-09